Welcome to our dedicated page for DiagnaMed Holdings news (Ticker: DGNMF), a resource for investors and traders seeking the latest updates and insights on DiagnaMed Holdings stock.
DiagnaMed Holdings Corp. reports company developments tied to its role as a Canadian technology company serving clean tech and life sciences markets, with recent updates centered on natural hydrogen initiatives. News commonly covers hydrogen extraction technology, soil-gas survey results in Ontario's Témiscamingue Graben, collaboration with Québec Innovative Materials Corp. and INRS, and agreements related to natural hydrogen development in the Ontario-Québec corridor. Other recurring updates address leadership changes, equity-incentive grants, shareholder voting matters, governance and capital-structure disclosures.
DiagnaMed (OTCQB: DGNMF) announced a corporate update as it advances a strategic focus on natural clean hydrogen exploration and development and its proposed transition to GeoHydrogen Corp., subject to regulatory and corporate approvals.
The company appointed Charles Turmel, an energy-focused business lawyer with experience in energy law, natural resources, decarbonization and corporate finance, to its Board of Directors, while director Fabio Chianelli resigned. DiagnaMed is advancing its Temiskaming Natural Hydrogen Project in Ontario, which includes an approximately 11-kilometre corridor of anomalous soil-gas hydrogen readings, including concentrations exceeding 2,000 ppm. In Nova Scotia, the Colchester East Natural Hydrogen Project spans 30 exploration licences totalling 2,104 mineral claims in the Cumberland Basin. The company continues its strategic technical advisory partnership with Québec Innovative Materials for exploration planning and geoscientific support and plans to keep progressing exploration and corporate steps tied to the proposed name change.
DiagnaMed Holdings (OTCQB: DGNMF) plans to change its name to GeoHydrogen Corp., subject to Canadian Securities Exchange (CSE) and corporate approvals, to reflect its exclusive focus on natural clean hydrogen exploration and development. Its CSE ticker is expected to change to GEOH, with a new CUSIP to follow.
The company is advancing two Canadian natural hydrogen projects: the Temiskaming project in Ontario, where soil-gas work has outlined an ~11 km corridor with hydrogen readings above 2,000 ppm, and the Colchester East project in Nova Scotia, covering 30 exploration licences and 2,104 mineral claims. DiagnaMed will continue its technical advisory partnership with Québec Innovative Materials (QIMC), which applies its proprietary R2G2 exploration framework across the portfolio. The name change will not alter the number of common shares or require shareholders to exchange share certificates.
DiagnaMed (OTCQB: DGNMF) extended its strategic technical advisory agreement with Quebec Innovative Materials Corp. (QIMC) to advance its Canadian natural hydrogen portfolio in Ontario and Nova Scotia. QIMC will refine priority targets at DiagnaMed's Temiskaming Natural Hydrogen Project in Ontario through infill soil gas sampling and geophysics over previously defined hydrogen anomalies.
Earlier work at Temiskaming identified soil gas hydrogen concentrations exceeding 2,000 ppm and outlined an 11-kilometre hydrogen-bearing corridor in the Temiskaming Graben, moving the project from reconnaissance to target refinement. In parallel, QIMC will launch the first systematic soil gas exploration program on DiagnaMed's newly acquired Colchester East Project in Nova Scotia, covering 30 exploration licences and 2,104 mineral claims in the Cumberland Basin. Upcoming milestones include completion of both soil gas programs, lab analysis, integrated interpretation and delineation of priority drill targets.
DiagnaMed (OTCQB:DGNMF, CSE:DMED) closed its acquisition of the Colchester East Natural Hydrogen Project in Nova Scotia, covering 30 licenses and 2,104 claims in the Cumberland Basin.
Consideration totaled $10,000 cash plus 10,000,000 shares at $0.06, a 2% gross revenue royalty, and an option to repurchase 50% of the royalty for $2,000,000. DiagnaMed also granted 7,000,000 options at $0.075, exercisable for two years.
DiagnaMed (OTCQB: DGNMF) entered an agreement to acquire the Colchester East Natural Hydrogen Project in Nova Scotia, comprising 30 licenses totalling 2,104 claims. The acquisition places DiagnaMed in a highly active natural hydrogen corridor adjacent to claims held by major players and complements its Ontario land position.
Deal terms include a $10,000 non-refundable cash payment, issuance of 10,000,000 common shares to sellers, a 2.0% royalty on hydrogen/mineral revenues and a repurchase option to buy back 50% of the royalty for $2,000,000. Transaction is subject to CSE approval and standard hold periods. DiagnaMed also appointed Fabrice Consalvo to its board to bolster energy expertise.
DiagnaMed (OTCQB: DGNMF) and QIMC reported new soil-gas results confirming a >11 km northward extension of the natural hydrogen system in Ontario's Témiscamingue Graben.
Across 454 samples on Lines 5–8 (45.3 km, 454 stations) the survey found 251 samples >500 ppm H2, 116 >1,000 ppm, 19 >2,000 ppm, and a peak of 2,817 ppm. The study area spans ~11.3 km N–S and 23 km E–W (~260 km²). Median H2 in the graben is 375 ppm versus 50–125 ppm in Abitibi sites; methane was detected in <3% of samples and average CO2 was 0.6%.
DiagnaMed (OTCQB: DGNMF) and QIMC announced a major natural hydrogen discovery in Ontario's Témiscamingue Graben on October 14, 2025. Of 456 soil-gas samples from four survey lines (July 8–21, 2025), 209 exceeded 500 ppm H2, with an average of 558 ppm and multiple peaks above 2,000 ppm. Anomalies align with deep faults beneath Quaternary sediments, supporting regional hydrogen migration. The program was run under INRS technical direction. An MOU with Témiscamingue First Nation was signed. Next steps include more survey lines, AMT/magnetic and radon-thoron mapping, and preliminary drilling site selection for 2026.
DiagnaMed (CSE: DMED / OTCQB: DGNMF) signed a Memorandum of Understanding on October 8, 2025 with Quebec Innovative Materials (CSE: QIMC) and Témiscamingue First Nation (TFN) to advance natural hydrogen development along the Ontario‑Quebec hydrogen corridor near Lake Témiscamingue.
The MOU creates a framework for cooperation emphasizing environmental stewardship, integration of Aboriginal Traditional Knowledge, economic participation for TFN members, in‑kind support for community projects, and quarterly progress meetings.
DiagnaMed Holdings Corp. (OTCQB: DGNMF) has announced key leadership appointments and provided an update on its natural hydrogen exploration program. The company has appointed André Turmel as Executive Chairman and Pam Sangster as Strategic Advisor.
The company has completed an extensive hydrogen soil sampling program in Ontario's Témiscamingue Graben, collecting over 1,000 soil-gas samples in collaboration with Quebec Innovative Materials Corp. (QIMC) and Institut National de la Recherche Scientifique (INRS). Results from this flagship program are expected to be released in the coming weeks.
DiagnaMed Holdings Corp. (OTCQB: DGNMF) announced two significant developments in its clean natural hydrogen initiatives. First, the company congratulated its partner Québec Innovative Materials Corp. (QIMC) on receiving a drill permit from the Quebec Government, validating their innovative exploration methods developed with INRS.
Additionally, DiagnaMed reported substantial progress in its Northern Ontario soil sampling program, completing 5 of 11 planned sampling lines with over 500 soil samples collected. The company's Ontario properties are strategically located on the geological continuation of QIMC's St-Bruno-de-Guigues assets, suggesting significant potential for clean natural hydrogen development.